Health care spending had been a rising share of US GDP for decades, but since about 2010, the rate of increase seemed to level out. David M. Cutler and Lev Klarnet address “Has the United States bent the health care cost curve?” (Brookings Papers on Economic Activity, Spring 2026, readable overview of paper at link, including a follow-up link to the paper itself).
Here’s an image to summarize the issue. Back in 1960, health care spending was about 5% of US GDP. But 2010, it was more like 17% of GDP (and remember, US GDP is a lot higher in 2010 than in 1960, so this is a rising share of a rising amount). But if you project forward from 2010, the rate of increase looks much slower.

Here’s a summary of the Cutler and Klarnet findings:
Aggregating across a number of data sets and analyses, we highlight the role of five central factors in the [health care] spending slowdown. First, technological innovation has become more likely to save money over time. This shows up in medications that prevent acute events and in surgeries that can be performed cheaper and with fewer complications. We estimate the development of cost saving technology accounts for about 21% of the spending slowdown. Second, demand for some types of care has fallen. Demand changes might be due to changes in reimbursement, higher cost sharing, and tighter insurer restrictions on utilization. Together, demand changes accounts for 10-26% of the spending slowdown, with the range reflecting economic uncertainty about effects. Third, long-run supply elasticities tend to be greater than short-run supply elasticities, leading to price reductions over time. Examples of this include pharmaceuticals going off patent and imaging prices declining. These account for 6% of the spending slowdown. Fourth, health status has improved in other ways that we do not understand, but that may be due to reduced smoking and other preventive care. A healthier population needs less care than does a less healthy one. These trends account for 7% of the spending slowdown. Fifth, there was a reduction in the rate of price growth, from 1-2% above general inflation to about general inflation. This results in about 24% of the spending slowdown. …
Considering our primary question, we conclude that the US has bent the health care cost curve. The role of technology in particular is fundamentally different from what it was in the past, and that means that cost growth has slowed relative to the past. That said, the cost curve has not bent as much as it could, or as much as it needs to.
The Cutler and Klarnet analysis of a slowdown in health care spending growth per person up through 2024 does not address the question of how an aging population is like to affect US health care spending moving forward. Economists at the Centers for Medicare and Medicaid Services do an annual forecast of health care expenditures looking ahead a decade, and I reviewed their most recent predictions last summer in “US Health Care Expenditures: An Ominous Trend Returns?” (July 1, 2025).
The CMS economists forecast that the aging of the population and the growth of Medicare enrollment are going to cause rise in health care spending from 17.6% of GDP in 2023 to 20.3% of GDP in the next decade. This rate of increase (that is, a rise of 2.5% of GDP in a decade) is similar to what happened from 1960 to 2010. Thus, one can think of the future of US health care spending as a tug-of-war between the Cutler-Klarnet list of factor that have been tending to hold down the rise in health care spending and the government forecasts of how population aging will tend to drive up health care spending.
Neither the rise in health care spending as a share of GDP nor the flattening of the curve has been solely a US phenonomen. Sheila Diane Smith and Joseph P. Newhouse take an international view on the topic in “Health-Care Spending Growth Has Slowed: Will the Bend in the Curve Continue?” (American Journal of Health Economics, Winter 2026, pp. 1-34). They offer this figure as a starting point. The top line shows US health care spending as a share of GDP. (The US line doesn’t match the line above because the OECD data shown below is defined differently from the measure used in the US GDP, but defined in a way that is identical across countries–thus offering a better basis for comparison.) The lower line shows an average for 19 other high-income countries. As they point out, the rise in health care spending as a share of GDP flattened out in these countries as well.
Smith and Newhouse summarize their findings based on the international data from 1970 up through 2019 (thus sidestepping effects of the pandemic on health care spending across countries starting in 2020). They write:
We find the 2009–19 slowdown [in the rise of health care costs] can be explained by lagged effects of the worldwide Great Recession, a decline in the contribution of exogenous technological change of 1.1 percentage points that began around 2004, and, in the US, a fall in medical prices relative to economy-wide prices. As in our earlier work, income and medical technology remain the main drivers of health-care cost in the entire 1970–2019 period, accounting for 43 percent and 35 percent of the growth in the US, respectively, and 57 percent and 21 percent of the growth in the OECD ex-US. …
Putting it all together, we project a post-COVID trend in real per capita growth in annual health-care spending for the United States of 2.6–2.7 percent from 2028 to 2038 versus 4.3 percent for 1970–2009, and 2.1–2.3 percent for the OECD ex-US from 2028 to 2038 versus 3.8 percent for 1970–2009. … This means the share of GDP in health care will increase on average by around 0.2 percentage points per year in the US and 0.1 percentage points in the OECD ex-US, with variation by country.
Thus, Smith and Newhouse argue the curve for health care spending as a share of GDP has been bent, but has not flattened out. Indeed, they project that US health care costs as a share of GDP will continue to rise faster than the average of the other 19 countries in their sample–rising another 2 percentage points per decade moving forward.
It’s worth emphasizing how much rides on the question of whether this shift toward flattening out the curve of health care spending as share of GDP turns out to be lasting, and perhaps even grows stronger. Government spending on health care at both the federal and state level (think Medicare and Medicaid) is a primary driver of future fiscal stress. An end to continuous increases in government health care spending would reduce that stress. Many US workers don’t see rising health care costs very clearly, because they are receiving employer-provided health insurance. But from the employers’ view, the amount they spend on health insurance for employees is part of the overall compensation package, and when employers need to pay more for health insurance, they have less to spend on take-home wages. From my own perspective, looming over all of these projections are the uncertainties about how many elderly people will–a decade or two from now–be needing some form of assisted care and the potential costs of those services.













